Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H13NO4S |
| Molecular Weight | 267.301 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C2SCCN(CC2=C1)C(=O)C(O)=O
InChI
InChIKey=FPWBHFYYVSNIFZ-UHFFFAOYSA-N
InChI=1S/C12H13NO4S/c1-17-9-2-3-10-8(6-9)7-13(4-5-18-10)11(14)12(15)16/h2-3,6H,4-5,7H2,1H3,(H,15,16)
| Molecular Formula | C12H13NO4S |
| Molecular Weight | 267.301 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
ARMGO and Servier are developing an anti-arrhythmia drug aladorian (ARM036) for the treatment of heart failure, arrhythmia and ventricular tachycardia. Aladorian was the first in-house discovered, novel, small molecule NCE (Rycal®) from ARMGO’s library that was advanced into clinical studies. ARM036 completed multiple Phase IIa clinical studies in chronic heart failure patients, demonstrating positive activity and safety in patients, and validating ARMGO’s approach for drug discovery and candidate selection on the RyR target.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.freepatentsonline.com/WO2008064264.html
Rats: 1.11 mg/kg/day ARM036 given via osmotic pump
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:16:33 GMT 2025
by
admin
on
Mon Mar 31 18:16:33 GMT 2025
|
| Record UNII |
PJ5KSA836G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
PJ5KSA836G
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY | |||
|
YY-112
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY | |||
|
11161474
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY | |||
|
865433-00-7
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY | |||
|
9614
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY | |||
|
C174843
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104951
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY | |||
|
300000034051
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY | |||
|
DTXSID40235657
Created by
admin on Mon Mar 31 18:16:33 GMT 2025 , Edited by admin on Mon Mar 31 18:16:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|